The first UK patient has been dosed with a personalised [...]
Kairos Pharma and Bayer will evaluate ENV-105 in combination with [...]
Kairos Pharma has reported positive interim safety results from an [...]
Erasca has reported updated preliminary Phase 1 data for its [...]
Evogene Ltd has partnered with Queensland University of Technology to [...]
MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]
Cemiplimab plus chemotherapy shows five-year survival benefit in advanced NSCLC Empower-lung 3 trial
Regeneron UK Limited has reported five-year follow-up results from the [...]